Biohaven Ltd Sustainability Reports
Biohaven Ltd. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing therapies for patients with debilitating neurological and neuropsychiatric diseases.
Sector: Manufacturing
Country: United States
Exchange: New York Stock Exchange
LEI: 5299007STZTNN32O9920
FIGI: BBG017BXV3R8
5 reports from 2018 to 2023
